DNB Asset Management AS Raises Position in Synopsys, Inc. $SNPS

DNB Asset Management AS boosted its holdings in shares of Synopsys, Inc. (NASDAQ:SNPSFree Report) by 220.4% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 128,881 shares of the semiconductor company’s stock after buying an additional 88,661 shares during the period. DNB Asset Management AS owned approximately 0.07% of Synopsys worth $63,589,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in the business. Alpine Bank Wealth Management boosted its position in shares of Synopsys by 89.3% during the 3rd quarter. Alpine Bank Wealth Management now owns 53 shares of the semiconductor company’s stock valued at $26,000 after acquiring an additional 25 shares during the last quarter. TFC Financial Management Inc. increased its position in shares of Synopsys by 1,250.0% in the third quarter. TFC Financial Management Inc. now owns 54 shares of the semiconductor company’s stock worth $27,000 after purchasing an additional 50 shares during the last quarter. Millstone Evans Group LLC purchased a new stake in Synopsys in the third quarter valued at approximately $27,000. SOA Wealth Advisors LLC. bought a new stake in Synopsys during the third quarter valued at approximately $28,000. Finally, McIlrath & Eck LLC purchased a new position in Synopsys in the 3rd quarter worth approximately $29,000. 85.47% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other Synopsys news, insider Janet Lee sold 250 shares of the stock in a transaction that occurred on Monday, January 12th. The stock was sold at an average price of $530.00, for a total value of $132,500.00. Following the completion of the sale, the insider owned 11,959 shares in the company, valued at approximately $6,338,270. This trade represents a 2.05% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CFO Shelagh Glaser sold 3,657 shares of Synopsys stock in a transaction that occurred on Friday, December 19th. The stock was sold at an average price of $460.77, for a total value of $1,685,035.89. Following the completion of the sale, the chief financial officer owned 17,842 shares in the company, valued at approximately $8,221,058.34. This represents a 17.01% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 4,157 shares of company stock valued at $1,945,036 in the last ninety days. 0.62% of the stock is currently owned by corporate insiders.

Synopsys Price Performance

Shares of Synopsys stock opened at $426.00 on Friday. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.62 and a quick ratio of 1.52. Synopsys, Inc. has a one year low of $365.74 and a one year high of $651.73. The business’s 50 day simple moving average is $472.21 and its two-hundred day simple moving average is $478.66. The stock has a market capitalization of $81.60 billion, a P/E ratio of 66.15, a price-to-earnings-growth ratio of 3.74 and a beta of 1.12.

Synopsys (NASDAQ:SNPSGet Free Report) last announced its quarterly earnings results on Wednesday, February 25th. The semiconductor company reported $3.77 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.56 by $0.21. The business had revenue of $2.41 billion for the quarter, compared to analyst estimates of $2.39 billion. Synopsys had a net margin of 13.76% and a return on equity of 7.49%. The company’s revenue was up 65.6% on a year-over-year basis. During the same quarter last year, the firm earned $3.03 EPS. Synopsys has set its FY 2026 guidance at 14.380-14.460 EPS and its Q2 2026 guidance at 3.110-3.170 EPS. Analysts forecast that Synopsys, Inc. will post 10.64 EPS for the current year.

Synopsys News Roundup

Here are the key news stories impacting Synopsys this week:

  • Positive Sentiment: Q1 beat and big revenue upside — Synopsys reported non‑GAAP EPS $3.77 (above estimates) and revenue of $2.409B, up ~65% YoY, driven by Design Automation and the Ansys contribution; headline results support longer‑term AI chip‑design demand. Synopsys Posts Financial Results for First Quarter Fiscal Year 2026
  • Positive Sentiment: Better FY26 EPS outlook — management set FY26 non‑GAAP EPS guidance ~14.38–14.46, well above consensus, suggesting management sees stronger full‑year earnings even if near‑term revenue cadence is choppy. Synopsys’ FY26 guidance likely conservative as analysts reiterate strong ratings
  • Positive Sentiment: $2.0B buyback — the board authorized up to $2B of repurchases, a direct capital return that can support the stock and offset dilution from the Ansys deal. Synopsys Posts Financial Results for First Quarter Fiscal Year 2026
  • Neutral Sentiment: Unusual options and whale activity — heavy call buying and large options volume were observed around the release, which can amplify intraday moves but may reflect short‑term, speculative positioning rather than conviction. Check Out What Whales Are Doing With SNPS
  • Negative Sentiment: Mixed/softer near‑term guide and China risk — investors reacted to a Q2 revenue guide some saw as light and to commentary about China export restrictions that could mute near‑term growth in that region. Those factors pressured the stock despite the beat. Synopsys forecasts muted quarter on China export restrictions, shares fall
  • Negative Sentiment: Acquisition costs, restructuring and debt concerns — reports note GAAP hit from Ansys integration, workforce reductions and the company’s elevated debt load from the transaction; these raise near‑term risk and make investors sensitive to guidance quality. Synopsys Stock (SNPS) Opinions on Earnings Release and AI Outlook
  • Negative Sentiment: Analysts trim targets and neutrality rises — several firms cut price targets or lowered ratings after the print (Wells Fargo, Piper Sandler among them), which can add selling pressure even as many analysts remain constructive on AI exposure. Analyst price target and rating changes

Analyst Ratings Changes

Several analysts have recently weighed in on the stock. Wells Fargo & Company lowered their price objective on shares of Synopsys from $500.00 to $450.00 and set an “equal weight” rating on the stock in a research report on Thursday. Citigroup started coverage on Synopsys in a research note on Monday, November 24th. They issued a “buy” rating and a $580.00 target price on the stock. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Synopsys in a research note on Thursday, January 22nd. The Goldman Sachs Group set a $600.00 price objective on Synopsys and gave the company a “buy” rating in a research report on Wednesday. Finally, KeyCorp raised their price objective on Synopsys from $575.00 to $600.00 and gave the company an “overweight” rating in a report on Thursday, December 11th. Nine research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, Synopsys currently has a consensus rating of “Hold” and an average target price of $535.67.

Check Out Our Latest Analysis on Synopsys

About Synopsys

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

Further Reading

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.